Stay updated on TAK-659 in AML Clinical Trial

Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-659 in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.4, replacing the previous v3.5.3. This indicates a version update rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-05-15T14:14:44.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s revision/version number has been updated from v3.5.2 to v3.5.3, indicating a minor site update without change to the underlying study details.
    Difference
    0.0%
    Check dated 2026-04-24T06:11:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:37:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added 'Acute myeloid leukemia' as a topic tag and included a new Resources link to the Genetic and Rare Diseases Information Center for AML information.
    Difference
    0.1%
    Check dated 2026-04-02T15:32:00.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.3 to v3.5.0. No changes to the trial content or page functionality are introduced.
    Difference
    0.0%
    Check dated 2026-03-19T04:53:05.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T02:16:14.000Z thumbnail image

Stay in the know with updates to TAK-659 in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.